Based in Boston as the co-founder and president of a biotech company, his interests lie in the intersection of systems medicine and AI. Several pharmaceuticals developed using his platform are advancing in late-stage clinical trials and being reviewed by the US Food and Drug Administration for treatment of conditions ranging from aggressive cancers to rare skin disorders and age-related muscle loss, and childhood mitochondrial disorders.

His work continues to shed light on cancers that behave more aggressively in Caribbean populations. In Guyana, he launched a technology-led project to improve understanding and management of Type 2 diabetes. Further, his collaborations between the Government of Guyana and legal and medical experts have led to the passage of important legislation, including Guyana’s Organ and Tissue Transplant Bill and the Suicide Prevention Bill.

For his skill in building global research connections and facilitating research that could lead to precision medicine for Caribbean people, Dr Narain is our Joint Science & Technology Laureate for 2026.